Heather L. Knight's most recent trade in Waters Corp. was a trade of 52 Common Stock done . Disclosure was reported to the exchange on March 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Waters Corp. | Heather L. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 52 | 613 (0%) | 0% | 0 | Common Stock | |
Baxter International Inc. | Heather L. Knight | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 118,934 | 118,934 | - | - | Stock Option (Right to Buy) | |
Baxter International Inc. | Heather L. Knight | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 35,674 | 177,362 (0%) | 0% | 0 | Common Stock, $1 par value | |
Baxter International Inc. | Heather L. Knight | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 13,634 | 141,688 (0%) | 0% | 35.4 | 483,189 | Common Stock, $1 par value |
Baxter International Inc. | Heather L. Knight | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.86 per share. | 03 Mar 2025 | 3,344 | 155,323 (0%) | 0% | 34.9 | 116,572 | Common Stock, $1 par value |
Waters Corp. | Heather L. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 818 | 818 | - | - | Stock Option (Right to Buy) | |
Waters Corp. | Heather L. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 319 | 560 (0%) | 0% | 0 | Common Stock | |
Waters Corp. | Heather L. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 72 | 241 (0%) | 0% | 0 | Common Stock | |
Baxter International Inc. | Heather L. Knight | EVP, Group Pres, Med Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.55 per share. | 02 Dec 2024 | 6,041 | 157,674 (0%) | 0% | 33.6 | 202,676 | Common Stock, $1 par value |
Waters Corp. | Heather L. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 32 | 168 (0%) | 0% | 0 | Common Stock | |
Waters Corp. | Heather L. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 349 | 349 | - | - | Stock Option (Right to Buy) | |
Waters Corp. | Heather L. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 136 | 136 (0%) | 0% | 0 | Common Stock | |
Baxter International Inc. | Heather L. Knight | EVP,Group Pres,Med Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 107,168 | 160,330 (0%) | 0% | 0 | Common Stock, $1 par value | |
Baxter International Inc. | Heather L. Knight | EVP,Group Pres, Med Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.50 per share. | 04 Mar 2024 | 1,320 | 53,162 (0%) | 0% | 42.5 | 56,100 | Common Stock, $1 par value |
Baxter International Inc. | Heather L. Knight | EVP, Group Pres, Med Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 2,154 | 54,483 (0%) | 0% | 41.0 | 88,336 | Common Stock, $1 par value |
Baxter International Inc. | Knight Heather L. | EVP, Group Pres, Med Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 1,027 | 56,958 (0%) | 0% | 0 | Common Stock, $1 par value | |
Baxter International Inc. | Heather Knight L. | EVP, Group Pres, Med Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.31 per share. | 12 Feb 2024 | 356 | 56,602 (0%) | 0% | 40.3 | 14,350 | Common Stock, $1 par value |
Baxter International Inc. | Heather L. Knight | EVP, Group Pres, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.19 per share. | 20 Mar 2023 | 212 | 53,110 (0%) | 0% | 38.2 | 8,096 | Common Stock, $1 par value |
Baxter International Inc. | Heather L. Knight | EVP, Group Pres, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.94 per share. | 03 Mar 2023 | 220 | 53,322 (0%) | 0% | 39.9 | 8,787 | Common Stock, $1 par value |
Baxter International Inc. | Heather L. Knight | EVP, Group Pres, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 1,067 | 53,543 (0%) | 0% | 39.6 | 42,275 | Common Stock, $1 par value |
Baxter International Inc. | Heather L. Knight | EVP, Group Pres, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 89,551 | 89,551 | - | - | Stock Option (Right to Buy) | |
Baxter International Inc. | Heather L. Knight | EVP, Group Pres, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 21,600 | 54,611 (0%) | 0% | 0 | Common Stock, $1 par value |